Significance of HLA-A*02 Positive in Diseases

Melanoma +

Breast Carcinoma +

Glioblastoma +

Glioma +

Non-Small Cell Lung Carcinoma +

Anal Carcinoma +

Cervical Carcinoma +

Multiple Myeloma +

Oropharyngeal Carcinoma +

Pancreatic Ductal Adenocarcinoma +

Synovial Sarcoma +

Acute Myeloid Leukemia +

Adenosquamous Lung Carcinoma +

Astrocytoma +

Bladder Urothelial Carcinoma +

Chronic Myeloid Leukemia +

Chronic Myelomonocytic Leukemia +

Diffuse Intrinsic Pontine Glioma +

Ductal Carcinoma In Situ +

Ependymoma +

Esophageal Adenocarcinoma +

Esophageal Squamous Cell Carcinoma +

Gastric Carcinoma +

Head And Neck Squamous Cell Carcinoma +

Hepatocellular Carcinoma +

Infiltrating Renal Pelvis And Ureter Urothelial Carcinoma +

Large Cell Lung Carcinoma +

Malignant Solid Tumor +

Myelodysplastic Syndromes +

Myxoid Liposarcoma +

Oligoastrocytoma +

Oligodendroglioma +

Oral Cavity Squamous Cell Carcinoma +

Ovarian Carcinoma +

Penile Carcinoma +

Primary Myelofibrosis +

Renal Pelvis Urothelial Carcinoma +

Smoldering Plasma Cell Myeloma +

Squamous Cell Lung Carcinoma +

Ureter Urothelial Carcinoma +

Urothelial Carcinoma +

Vaginal Carcinoma +

Vulvar Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.